Tablet: Symptomatic treatment of allergic rhinitis and urticaria in adults and adolescents (12 year and above).
Oral solution: Rupafin 1 mg/ml oral solution is indicated for the symptomatic treatment of: Allergic rhinitis (including persistent allergic rhinitis) in children aged 2 to 11 years (see Pharmacology: Pharmacodynamics under Actions); Urticaria in children aged 2 to 11 years (see Pharmacology: Pharmacodynamics under Actions).